Vasilopoulou MΑ, Ioannou E, Roussis V, Chondrogianni N (2021) Modulation of the ubiquitin-proteasome system by marine natural products. Redox Biology 41:101897. https://doi.org/10.1016/j.redox.2021.101897
Article PubMed CAS Google Scholar
Kaur N, Raja R, Ruiz-Velasco A, Liu W (2020) Cellular protein quality control in diabetic cardiomyopathy: from bench to bedside. Front Cardiovasc Med 7:585309. https://doi.org/10.3389/fcvm.2020.585309
Article PubMed PubMed Central CAS Google Scholar
Sharma A, Khan H, Singh TG et al (2021) Pharmacological modulation of ubiquitin-proteasome pathways in oncogenic signaling. Int J Mol Sci 22:11971. https://doi.org/10.3390/ijms222111971
Article PubMed PubMed Central CAS Google Scholar
Miller MA, Zachary JF (2017) Mechanisms and morphology of cellular injury, adaptation, and death. Pathol Basis Vet Dis 2–43:e19. https://doi.org/10.1016/B978-0-323-35775-3.00001-1
Livnat-Levanon N, Glickman MH (2011) Ubiquitin-proteasome system and mitochondria - reciprocity. Biochim Biophys Acta 1809:80–87. https://doi.org/10.1016/j.bbagrm.2010.07.005
Article PubMed CAS Google Scholar
Gupta A, Behl T, Aleya L et al (2021) Role of UPP pathway in amelioration of diabetes-associated complications. Environ Sci Pollut Res Int 28:19601–19614. https://doi.org/10.1007/s11356-021-12781-5
Shen M, Schmitt S, Buac D, Dou QP (2013) Targeting the ubiquitin-proteasome system for cancer therapy. Expert Opin Ther Targets 17:1091–1108. https://doi.org/10.1517/14728222.2013.815728
Article PubMed PubMed Central CAS Google Scholar
Bingol B, Schuman EM (2005) Synaptic protein degradation by the ubiquitin proteasome system. Curr Opin Neurobiol 15:536–541. https://doi.org/10.1016/j.conb.2005.08.016
Article PubMed CAS Google Scholar
Dantuma NP, Bott LC (2014) The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution. Front Mol Neurosci 7:70. https://doi.org/10.3389/fnmol.2014.00070
Article PubMed PubMed Central CAS Google Scholar
Rehni AK, Singh TG, Behl N, Arora S (2010) Possible involvement of ubiquitin proteasome system and other proteases in acute and delayed aspects of ischemic preconditioning of brain in mice. Biol Pharm Bull 33:1953–1957. https://doi.org/10.1248/bpb.33.1953
Article PubMed CAS Google Scholar
Brown NG, VanderLinden R, Watson ER et al (2015) RING E3 mechanism for ubiquitin ligation to a disordered substrate visualized for human anaphase-promoting complex. Proc Natl Acad Sci 112:5272–5279. https://doi.org/10.1073/pnas.1504161112
Article PubMed PubMed Central CAS Google Scholar
Schulman BA, Wade Harper J (2009) Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways. Nat Rev Mol Cell Biol 10:319–331. https://doi.org/10.1038/nrm2673
Article PubMed PubMed Central CAS Google Scholar
Chopra G, Shabir S, Yousuf S et al (2022) Proteinopathies: deciphering physiology and mechanisms to develop effective therapies for neurodegenerative diseases. Mol Neurobiol 59:7513–7540. https://doi.org/10.1007/s12035-022-03042-8
Article PubMed CAS Google Scholar
Magnati S, Alladio E, Bracco E (2024) A survey on the expression of the ubiquitin proteasome system components HECT- and RBR-E3 ubiquitin ligases and E2 ubiquitin-conjugating and E1 ubiquitin-activating enzymes during human brain development. Int J Mol Sci 25:2361. https://doi.org/10.3390/ijms25042361
Article PubMed PubMed Central CAS Google Scholar
Koegl M, Hoppe T, Schlenker S et al (1999) A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 96:635–644. https://doi.org/10.1016/S0092-8674(00)80574-7
Article PubMed CAS Google Scholar
Liu B, Ruan J, Chen M et al (2022) Deubiquitinating enzymes (DUBs): decipher underlying basis of neurodegenerative diseases. Mol Psychiatry 27:259–268. https://doi.org/10.1038/s41380-021-01233-8
Article PubMed CAS Google Scholar
van der Wal L, Bezstarosti K, Demmers JAA (2022) A ubiquitinome analysis to study the functional roles of the proteasome associated deubiquitinating enzymes USP14 and UCH37. J Proteomics 262:104592. https://doi.org/10.1016/j.jprot.2022.104592
Article PubMed CAS Google Scholar
Qin B, Chen X, Wang F, Wang Y (2024) DUBs in Alzheimer’s disease: mechanisms and therapeutic implications. Cell Death Discov 10:475. https://doi.org/10.1038/s41420-024-02237-3
Article PubMed PubMed Central Google Scholar
Mumtaz I, Ayaz MO, Khan MS et al (2022) Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer’s disease. Front Aging Neurosci 14:977411. https://doi.org/10.3389/fnagi.2022.977411
Article PubMed PubMed Central CAS Google Scholar
Tai H-C, Schuman EM (2008) Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction. Nat Rev Neurosci 9:826–838. https://doi.org/10.1038/nrn2499
Article PubMed CAS Google Scholar
Vijayaragavan K, Cannon BJ, Tebaykin D et al (2022) Single-cell spatial proteomic imaging for human neuropathology. Acta Neuropathol Commun 10:158. https://doi.org/10.1186/s40478-022-01465-x
Article PubMed PubMed Central Google Scholar
Rajgor D, Welle TM, Smith KR (2021) The coordination of local translation, membranous organelle trafficking, and synaptic plasticity in neurons. Front Cell Dev Biol 9:711446. https://doi.org/10.3389/fcell.2021.711446
Article PubMed PubMed Central Google Scholar
Momtaz S, Memariani Z, El-Senduny FF et al (2020) Targeting ubiquitin-proteasome pathway by natural products: novel therapeutic strategy for treatment of neurodegenerative diseases. Front Physiol 11:361. https://doi.org/10.3389/fphys.2020.00361
Article PubMed PubMed Central Google Scholar
Zhang J, Zhang Y, Wang J et al (2024) Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies. Sig Transduct Target Ther 9:211. https://doi.org/10.1038/s41392-024-01911-3
Kim J, Byun I, Young Kim D et al (2024) Targeted protein degradation directly engaging lysosomes or proteasomes. Chem Soc Rev 53:3253–3272. https://doi.org/10.1039/D3CS00344B
Article PubMed CAS Google Scholar
Hyun S, Shin D (2021) Chemical-mediated targeted protein degradation in neurodegenerative diseases. Life 11:607. https://doi.org/10.3390/life11070607
Article PubMed PubMed Central CAS Google Scholar
Potjewyd FM, Axtman AD (2021) Exploration of aberrant E3 ligases implicated in Alzheimer’s disease and development of chemical tools to modulate their function. Front Cell Neurosci 15:768655. https://doi.org/10.3389/fncel.2021.768655
Article PubMed PubMed Central CAS Google Scholar
Al Mamun A, Uddin MdS, Kabir MdT et al (2020) Exploring the promise of targeting ubiquitin-proteasome system to combat Alzheimer’s disease. Neurotox Res 38:8–17. https://doi.org/10.1007/s12640-020-00185-1
Comments (0)